Axsome Therapeutics Stock Price on December 9, 2024
| AXSM Stock | USD 89.74 0.93 1.03% |
Below is the normalized historical share price chart for Axsome Therapeutics extending back to November 19, 2015. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Axsome Therapeutics stands at 89.74, as last reported on the 20th of December, with the highest price reaching 92.00 and the lowest price hitting 88.31 during the day.
If you're considering investing in Axsome Stock, it is important to understand the factors that can impact its price. Axsome Therapeutics secures Sharpe Ratio (or Efficiency) of -0.001, which signifies that the company had a -0.001% return per unit of risk over the last 3 months. Axsome Therapeutics exposes twenty-eight different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Axsome Therapeutics' Risk Adjusted Performance of 0.0069, mean deviation of 1.81, and Downside Deviation of 2.15 to double-check the risk estimate we provide.
At this time, Axsome Therapeutics' Total Stockholder Equity is very stable compared to the past year. As of the 20th of December 2024, Liabilities And Stockholders Equity is likely to grow to about 617.6 M, while Common Stock Shares Outstanding is likely to drop about 30.1 M. . At this time, Axsome Therapeutics' Price Book Value Ratio is very stable compared to the past year. As of the 20th of December 2024, Price To Book Ratio is likely to grow to 19.88, while Price Earnings Ratio is likely to drop (15.87). Axsome Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 19th of November 2015 | 200 Day MA 83.501 | 50 Day MA 93.0122 | Beta 1.252 |
Axsome |
Sharpe Ratio = -0.001
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | AXSM |
Estimated Market Risk
| 2.46 actual daily | 21 79% of assets are more volatile |
Expected Return
| 0.0 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.0 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Axsome Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Axsome Therapeutics by adding Axsome Therapeutics to a well-diversified portfolio.
Price Book 47.3001 | Enterprise Value Ebitda (14.81) | Price Sales 12.9827 | Shares Float 36.1 M | Wall Street Target Price 130.4706 |
Related Headline
Incyte Headline on 9th of December 2024
Incytes Late-stage NSCLC Study Meets Primary and Secondary G... by finance.yahoo.com
INCYs phase III study, evaluating retifanlimab in combination with platinum-based chemotherapy for the treatment of metastatic non-small cell lung cancer, meets primary and secondary endpoints.
Axsome Therapeutics Valuation on December 9, 2024
It is possible to determine the worth of Axsome Therapeutics on a given historical date. On December 9, 2024 Axsome was worth 100.21 at the beginning of the trading date compared to the closed value of 99.76. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Axsome Therapeutics stock. Still, in general, we apply an absolute valuation method to find Axsome Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Axsome Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Axsome Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 98.33 | 100.24 | 98.16 | 100.10 | 346,647 | |
12/09/2024 | 100.21 | 102.30 | 97.59 | 99.76 | 353,224 |
| 100.12 | 100.12 | 97.60 | 98.82 | 390,534 |
| Backtest Axsome Therapeutics | | | Axsome Therapeutics History | | | Axsome Therapeutics Valuation | Previous | Next |
Axsome Therapeutics Trading Date Momentum on December 9, 2024
| On December 10 2024 Axsome Therapeutics was traded for 98.82 at the closing time. The top price for the day was 100.12 and the lowest listed price was 97.60 . The trading volume for the day was 390.5 K. The trading history from December 10, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 0.94% . The overall trading delta against the current closing price is 8.88% . |
Axsome Therapeutics Fundamentals Correlations and Trends
By evaluating Axsome Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Axsome Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Axsome financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Axsome Therapeutics Stock history
Axsome Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Axsome is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Axsome Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Axsome Therapeutics stock prices may prove useful in developing a viable investing in Axsome Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 45.4 M | 30.1 M | |
| Net Loss | -168.4 M | -160 M |
Axsome Therapeutics Quarterly Net Working Capital |
|
Axsome Therapeutics Stock Technical Analysis
Axsome Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Axsome Therapeutics Period Price Range
Low | December 20, 2024
| High |
0.00 | 0.00 |
Axsome Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Axsome Therapeutics December 20, 2024 Market Strength
Market strength indicators help investors to evaluate how Axsome Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Axsome Therapeutics shares will generate the highest return on investment. By undertsting and applying Axsome Therapeutics stock market strength indicators, traders can identify Axsome Therapeutics entry and exit signals to maximize returns
Axsome Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Axsome Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Axsome Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Axsome to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0069 | |||
| Jensen Alpha | (0.03) | |||
| Total Risk Alpha | (0.08) | |||
| Sortino Ratio | (0.02) | |||
| Treynor Ratio | (0.01) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Axsome Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. To learn how to invest in Axsome Stock, please use our How to Invest in Axsome Therapeutics guide.You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Axsome Therapeutics. If investors know Axsome will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Axsome Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (6.58) | Revenue Per Share 7.108 | Quarterly Revenue Growth 0.813 | Return On Assets (0.26) | Return On Equity (1.72) |
The market value of Axsome Therapeutics is measured differently than its book value, which is the value of Axsome that is recorded on the company's balance sheet. Investors also form their own opinion of Axsome Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Axsome Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Axsome Therapeutics' market value can be influenced by many factors that don't directly affect Axsome Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Axsome Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Axsome Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Axsome Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.